KR20190110563A - 지방 유제, 및 그 제조 방법, 지방 유제의 안정성을 향상시키는 방법, 그리고 지방 유제의 안정성 향상제 - Google Patents

지방 유제, 및 그 제조 방법, 지방 유제의 안정성을 향상시키는 방법, 그리고 지방 유제의 안정성 향상제 Download PDF

Info

Publication number
KR20190110563A
KR20190110563A KR1020197023284A KR20197023284A KR20190110563A KR 20190110563 A KR20190110563 A KR 20190110563A KR 1020197023284 A KR1020197023284 A KR 1020197023284A KR 20197023284 A KR20197023284 A KR 20197023284A KR 20190110563 A KR20190110563 A KR 20190110563A
Authority
KR
South Korea
Prior art keywords
histidine
fat emulsion
emulsion
mass
content
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020197023284A
Other languages
English (en)
Korean (ko)
Inventor
요헤이 아마노
Original Assignee
큐피가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 큐피가부시키가이샤 filed Critical 큐피가부시키가이샤
Priority to KR1020217034425A priority Critical patent/KR102421538B1/ko
Publication of KR20190110563A publication Critical patent/KR20190110563A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Colloid Chemistry (AREA)
  • Cosmetics (AREA)
KR1020197023284A 2017-02-07 2017-05-08 지방 유제, 및 그 제조 방법, 지방 유제의 안정성을 향상시키는 방법, 그리고 지방 유제의 안정성 향상제 Ceased KR20190110563A (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020217034425A KR102421538B1 (ko) 2017-02-07 2017-05-08 지방 유제, 및 그 제조 방법, 지방 유제의 안정성을 향상시키는 방법, 그리고 지방 유제의 안정성 향상제

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2017020377 2017-02-07
JPJP-P-2017-020377 2017-02-07
PCT/JP2017/017378 WO2018146829A1 (fr) 2017-02-07 2017-05-08 Émulsion de graisse ainsi que procédé de fabrication de celle-ci, procédé d'amélioration de stabilité d'émulsion de graisse, et agent d'amélioration de stabilité d'émulsion de graisse

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020217034425A Division KR102421538B1 (ko) 2017-02-07 2017-05-08 지방 유제, 및 그 제조 방법, 지방 유제의 안정성을 향상시키는 방법, 그리고 지방 유제의 안정성 향상제

Publications (1)

Publication Number Publication Date
KR20190110563A true KR20190110563A (ko) 2019-09-30

Family

ID=63108143

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020197023284A Ceased KR20190110563A (ko) 2017-02-07 2017-05-08 지방 유제, 및 그 제조 방법, 지방 유제의 안정성을 향상시키는 방법, 그리고 지방 유제의 안정성 향상제
KR1020217034425A Active KR102421538B1 (ko) 2017-02-07 2017-05-08 지방 유제, 및 그 제조 방법, 지방 유제의 안정성을 향상시키는 방법, 그리고 지방 유제의 안정성 향상제

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020217034425A Active KR102421538B1 (ko) 2017-02-07 2017-05-08 지방 유제, 및 그 제조 방법, 지방 유제의 안정성을 향상시키는 방법, 그리고 지방 유제의 안정성 향상제

Country Status (5)

Country Link
JP (1) JP6550175B2 (fr)
KR (2) KR20190110563A (fr)
CN (1) CN108712902A (fr)
TW (1) TWI803478B (fr)
WO (1) WO2018146829A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109223712B (zh) * 2018-10-10 2020-06-02 武汉大安制药有限公司 氟比洛芬酯注射用乳剂及其制备方法
CN112545980A (zh) * 2019-09-25 2021-03-26 北京普德康利医药科技发展有限公司 低含量氟比洛芬酯药物组合物及其应用
JP6832468B1 (ja) * 2020-07-15 2021-02-24 キユーピー株式会社 エマルジョン、注射剤、及びエマルジョンを調製する方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0543450A (ja) * 1991-08-09 1993-02-23 Green Cross Corp:The 凍結乾燥製剤
JPH0881360A (ja) * 1994-07-13 1996-03-26 Wakamoto Pharmaceut Co Ltd 安定な脂肪乳剤
US5693337A (en) * 1994-07-13 1997-12-02 Wakamoto Pharmaceutical Co., Ltd. Stable lipid emulsion
CN102988291B (zh) * 2012-12-13 2014-05-14 哈药集团技术中心 一种氟比洛芬酯脂肪乳注射液组合物及其制备方法
CN105106115A (zh) * 2015-10-10 2015-12-02 北京蓝丹医药科技有限公司 一种稳定的丙泮尼地脂肪乳

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
의약품 인터뷰 폼 (전신 마취·진정용제 1 ％ 디프리반 (등록 상표) 주), 2015년 1월 개정 (개정 제15판)
의약품 인터뷰 폼 (정주용 비스테로이드성 진통제 로피온 (등록 상표) 정주 50 mg), 2015년 9월 개정 (제9판)
의약품 인터뷰 폼 (합성 부신피질 호르몬제 리메타손 (등록 상표) 정주 2.5 mg), 2012년 2월 개정 (제10판)

Also Published As

Publication number Publication date
TW201828935A (zh) 2018-08-16
WO2018146829A1 (fr) 2018-08-16
CN108712902A (zh) 2018-10-26
JP2018150387A (ja) 2018-09-27
TWI803478B (zh) 2023-06-01
KR20210132228A (ko) 2021-11-03
JP6550175B2 (ja) 2019-07-24
KR102421538B1 (ko) 2022-07-14

Similar Documents

Publication Publication Date Title
CN107205920B (zh) 可注射丁丙诺啡制剂
US20180256496A1 (en) Controlled-release formulations
US20220387445A1 (en) Prostacyclin analogue formulations
JP2013508312A (ja) ｐＨ調節剤を含むタキサンの医薬溶液、およびその作製方法
KR20190110563A (ko) 지방 유제, 및 그 제조 방법, 지방 유제의 안정성을 향상시키는 방법, 그리고 지방 유제의 안정성 향상제
WO2012133554A1 (fr) Émulsion grasse contenant une prostaglandine
JP2014224131A (ja) プロスタグランジンｅ１を含む安定な脂肪乳剤
JP2019210222A (ja) 水中油型乳化組成物及びその製造方法
CN112188898A (zh) 缓释肽配制品
JP6368862B1 (ja) 脂肪乳剤、及びその製造方法、脂肪乳剤の安定性を向上させる方法、並びに脂肪乳剤の安定性向上剤
WO2011145660A1 (fr) Composition d'émulsion d'huile dans l'eau contenant du propofol
JP4707839B2 (ja) 糖尿病予防治療剤
WO2016047664A1 (fr) Composition d'émulsion huile-dans-l'eau contenant du propofol, et son procédé de production
JP5759804B2 (ja) 容器詰製剤
CN109985005A (zh) 氟比洛芬酯脂肪乳及其制备方法
JP2013001700A (ja) プロポフォール含有水中油型エマルション組成物
JP2012214430A (ja) プロスタグランジン含有脂肪乳剤
WO2019230964A1 (fr) Composition d'émulsion de type huile dans eau conditionnée
CN107412160B (zh) 一种含前列腺素的脂肪乳剂及其制备方法
TW202608471A (zh) 脂質組成物及使用其之方法
CN109985002A (zh) 一种氟比洛芬酯脂肪乳及其制备方法

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20190807

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20200109

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20210319

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20210923

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20210319

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20211022